Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project(aEuro)

Volume
26
Pagination
2392 - 2398
DOI
10.1093/annonc/mdv380
Journal
ANNALS OF ONCOLOGY
Issue
12
ISSN
0923-7534
Metadata
Show full item record
Authors
Kramar, A; Negrier, S; Sylvester, R; Joniau, S; Mulders, P; Powles, T; Bex, A; Bonnetain, F; Bossi, A; Bracarda, S
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11012
Collections
Licence information
• “The final publication is available at http://annonc.oxfordjournals.org/content/26/12/2392.long”